Literature DB >> 30745190

A novel naloxone training compared with current recommended training in an overdose simulation.

Thomas S Franko, Danielle Distefano, Lauren Lewis.   

Abstract

OBJECTIVES: The aim of this study was to determine if a novel naloxone training program with a focus on situational stress management yields better results than the currently recommended state training in a simulated overdose response.
METHODS: Students were randomized to receive either the state training or a novel training developed by the Wilkes University Nesbitt School of Pharmacy. After their respective training, each student individually completed a live simulated overdose response with an added stressor of a panicked bystander. A checklist was used to evaluate students during the simulation, and the results were compared.
RESULTS: The average grade for the novel training students was 89% compared with 64% for the state training students (P < 0.001). There was no statistically significant difference in time to complete the simulation.
CONCLUSION: Students who underwent the novel training received the state training. The novel training appears to be effective in preparing students to manage a live opioid overdose.
Copyright © 2019 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 30745190     DOI: 10.1016/j.japh.2018.12.022

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  2 in total

1.  Resuscitation simulation among people who are likely to witness opioid overdose: Experiences from the SOONER Trial.

Authors:  Jonathan P Whittall; Aaron M Orkin; Curtis Handford; Michelle Klaiman; Pamela Leece; Mercy Charles; Amy Wright; Suzanne Turner; Laurie J Morrison; Carol Strike; Douglas M Campbell
Journal:  PLoS One       Date:  2022-07-05       Impact factor: 3.752

Review 2.  First Aid Education for Opioid Overdose Poisoning: Scoping Review.

Authors:  Jeffrey L Pellegrino; Jamillee L Krob; Aaron Orkin
Journal:  Cureus       Date:  2021-01-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.